ExploreWatchlistsPricing
  1. JP-listed companies
  2. Linical Co., Ltd.
  3. Financials
  4. Total assets

Linical Co., Ltd. (2183)

Market cap
¥5.1B
P/E ratio
25.7x
Linical helps pharmaceutical companies develop and launch new drugs by providing clinical trial services, post-market safety monitoring, and drug discovery support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 202612,000-28.47%
Mar 31, 202516,775-9.52%
Mar 31, 202418,540+6.16%
Mar 31, 202317,465+11.12%
Mar 31, 202215,716+2.85%
Mar 31, 202115,281+7.15%
Mar 31, 202014,261+7.56%
Mar 31, 201913,259+43.38%
Mar 31, 20189,247+11.41%
Mar 31, 20178,300+16.54%
Mar 31, 20167,122+26.23%
Mar 31, 20155,642

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat